Otwarty dostęp

Effect of upright and ambulant positions versus lying down during the active first stage of labor on birth outcomes among nulliparous women: randomized controlled clinical trial


Zacytuj

Cesarean birth rates, oxytocin use, and labor stages duration among parturient women in the two groups (n = 150).

CharacteristicStudy group (n = 75)Control group (n = 75)Significant testP-value
Mode of delivery (cesarean birth rates)
Spontaneous vaginal delivery6384.05978.70.703a0.402
Lower segment cesarean section (LSCS)1216.01621.3
Use of oxytocin augmentation
No1925.31317.31.430a0.232
Yes5674.76282.7
Duration of labor stages
First stage (h)11.88 ± 2.5012.74 ± 1.862.387b0.018*
Second stage (min)62.40 ± 8.0865.47 ± 12.651.727b0.086
Third stage (min)11.53 ± 2.3211.77 ± 3.610.478b0.633

Demographic characteristics, BMI, and weeks of gestation of parturient women in the two groups (n = 150).

ItemsStudy groupControl groupSignificant testP-value
n = 75%n = 75%
Age (years)
  ≤20810.768.0
  21–346080.06789.33.347b0.164
  ≥3579.322.7
Education
  Read and write1722.7810.74.684a0.096
  Secondary4458.74661.3
  University1418.72128.0
Working status
  Working1824.02128.00.312a0.577
  House wife5776.05472.0
Residence
  Rural6080.05472.01.316a0.251
  Urban1520.02128.0
BMI (M ± SD)25.62 ± 2.5926.38 ± 2.300.448c0.655
Gestational weeks (M ± SD)38.37 ± 0.6738.68 ± 0.980.097c0.923

Neonates’ outcome between the two groups (M ± SD).

CharacteristicStudy group (n = 75)Control group (n = 75)tP-value
Baby birth weight (kg)2.96 ± 0.342.92 ± 0.280.7730.441
Baby head circumference (cm)33.54 ± 1.4533.52 ± 1.480.1080.914
Apgar's score at 1 min6.92 ± 1.367.20 ± 1.200.9120.363
Apgar's score at 5 min8.98 ± 1.199.28 ± 1.511.1890.236

Labor progress of parturients in the two groups (M± SD).

GroupBaselineAt first hourAt second hourAt third hourAt forth hourAt fifth hourAt sixth hourAt seventh hourF for timeF for group
1-Duration of uterine contractions (s)
Study (n = 75)25.40 ± 5.1531.80 ± 3.9935.80 ± 3.4541.60 ± 2.8145.80 ± 7.4952.20 ± 5.7759.40 ± 5.0764.60 ± 4.9527.8721.686
Control (n = 75)24.60 ± 5.4930.20 ± 5.7734.40 ± 3.0239.00 ± 6.1445.60 ± 3.6951.40 ± 5.8953.80 ± 3.9962.40 ± 5.64
t (P-value)0. 919 (0.360)1.972 (0.051)2.641 (0.009)3.333 (0.001)**0.218 (0.827)0.840 (0.403)7.505 (0.001)**2.536 (0.012)*0.000**0.196
2-Interval of uterine contractions (min)
Study (n = 75)4.70 ± 0.754.01 ± 0.713.71 ± 0.513.40 ± 0.373.02 ± 0.312.90 ± 0.202.50 ± 0.312.03 ± 0.5518.50627.160
Control (n = 75)4.82 ± 0.604.42 ± 0.584.32 ± 0.593.91 ± 0.483.31 ± 0.423.02 ± 0.412.96 ± 0.372.10 ± 0.49
t (P-value)1.074 (0.285)3.957 (0.000)**7.413 (0.000)**7.268 (0.000)**5.061 (0.000)**2.363 (0.019)*7.171 (0.000)**1.148 (0.253)0.000**0.000**
3-frequency of uterine contractions/10 min
Study (n = 75)2.40 ± 0.432.60 ± 0.422.80 ± 0.402.82 ± 0.422.85 ± 0.463.00 ± 0.633.40 ± 0.494.20 ± 0.752.0858.667
Control (n = 75)2.37 ± 0.0.482.40 ± 0.492.58 ± 0.472.60 ± 0.572.63 ± 0.612.94 ± 0.653.17 ± 0.413.93 ± 0.68
t (P-value)0.333 (0.739)2.483 (0.014)*2.893 (0.004)*3.065 (0.003)*3.058 (0.003)*0.490 (0.614)3.054 (0.003)*2.269 (0.025)*0.043*0.004*
4-Cervical dilatation (cm)
Study (n = 75)3.40 ± 0.543.20 ± 0.404.12 ± 0.515.94 ± 0.676.81 ± 0.747.85 ± 0.848.94 ± 0.849.95 ± 0.2112.4800.146
Control (n = 75)3.45 ± 0.503.17 ± 0.384.01 ± 0.585.62 ± 0.956.62 ± 0.957.62 ± 0.948.62 ± 0.959.78 ± 0.47
t (P-value)0.657 (0.512)0.417 (0.678)1.186 (0.238)2.368 (0.019)*1.332 (0.185)1.536 (0.127)2.164 (0.032)*2.467 (0.015)*0.001**0.033*
5-Fetal head descent/fifth
Study (n = 75)2.97 ± 0.672.41 ± 0.502.00 ± 0.631.40 ± 0.490.61 ± 0.440.37 ± 0.450.21 ± 0.400.14 ± 0.415.46712.530
Control (n = 75)3.01 ± 0.702.45 ± 0.520.04 ± 0.661.46 ± 0.570.82 ± 0.700.53 ± 0.550.44 ± 0.540.35 ± 0.53
t (P-value)0.354 (0.724)0.479 (0.633)0.376 (0.708)0.657 (0.512)2.152 (0.033)*1.880 (0.062)2.555 (0.012)*2.077 (0.041)*0.022*0.001**
6-Fetal heart rates B/M
Study (n = 75)135.72 ± 8.64136.44 ± 8.84133.80 ± 7.74130.92 ± 9.43133.06 ± 7.57133.77 ± 8.72130.33 ± 8.88128.46 ± 9.490.5071.299
Control (n = 75)133.73 ± 8.38134.81 ± 9.31132.80 ± 8.31131.08 ± 8.07131.00 ± 0.10131.98 ± 7.92128.18 ± 9.32129.37 ± 8.01
t (P-value)1.444 (0.151)1.097 (0.275)0.762 (0.447)0.112 (0.911)1.424 (0.157)0.776 (0.439)1479 (0.141)0.632 (0.528)0.4780.256
7-Pain scores (visual pain analogue scale)
Study (n = 75)7.29 ± 0.617.70 ± 0.457.77 ± 0.428.21 ± 0.598.86 ± 0.349.30 ± 0.469.48 ± 1.259.61 ± 1.2716.6830.039
Control (n = 75)7.22 ± 0.537.76 ± 0.427.80 ± 0.408.25 ± 0.638.92 ± 0.399.33 ± 0.509.52 ± 0.549.53 ± 0.53
t (P-value)0.712 (0.478)0.735 (0.464)0.396 (0.693)0.395 (0.693)0.884 (0.378)0.348 (0.728)0.256 (0.798)0.514 (0.608)0.000**0.843

Neonates’ admission to Neonatal Intensive Care Unit (NICU) (n = 150).

Neonates’ admission to NICUStudy group (n = 75)Control group (n = 75)Significant testP-value
Yes34.056.70.528a0.467
No7296.07093.3
eISSN:
2544-8994
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medicine, Assistive Professions, Nursing